Abstract | OBJECTIVE: To detect chromosomal aberrations by using cytoplasmic light chain immunofluorescence with fluorescence in situ hybridization (cIg-FISH), and to explore the correlation of del(17p13) with clinical characteristics, drug response and prognosis among patients with newly diagnosed multiple myeloma (NDMM). METHODS: Clinical data of 198 cases of NDMM was collected. cIg-FISH and a specific probe (TP53) were used to detect karyotypic abnormalities in bone marrow samples derived from the patients. Correlation between karyotypic abnormalities and clinical data was analyzed. RESULTS: Nineteen of the 198 patients (9.6%) were found to have a karyotype involving del(17p13). The overall survival (OS) and progression-free survival (PFS) for patients with or without del(17p13) was significantly different (P<0.01). No significant difference was found in OS and PFS between patients carrying a del(17p13) on bortezomib and non- bortezomib regimen (OS: P = 0.873; PFS: P = 0.610). CONCLUSION:
|
Authors | Xiupan Lu, Lijuan Chen, Qinglin Shi, Hairong Qiu, Jianyong Li, Rui Guo |
Journal | Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
(Zhonghua Yi Xue Yi Chuan Xue Za Zhi)
Vol. 37
Issue 10
Pg. 1087-1091
(Oct 10 2020)
ISSN: 1003-9406 [Print] China |
PMID | 32924107
(Publication Type: Journal Article)
|
Topics |
- Chromosome Deletion
- Chromosomes, Human, Pair 17
- Fluorescent Antibody Technique
- Humans
- In Situ Hybridization, Fluorescence
- Karyotyping
- Multiple Myeloma
(diagnosis, genetics)
- Prognosis
|